DuoGenic StemCells corporation Total Liabilities

The latest total liabilities for 7607.TWO is $35M as of June 2026. That compares with $39M in the prior-year period — down 10.1% year over year. Investors often review this figure alongside DuoGenic StemCells corporation's historical trend and sector peers before judging valuation or financial health.

Over the past year, 7607.TWO's total liabilities moved from $39M to $35M — a 10.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in DuoGenic StemCells corporation's operating scale or balance-sheet position.

A total liabilities figure of $35M for 7607.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 7607.TWO's total liabilities ($35M), review year-over-year change from $39M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.